GE Healthcare is to invest up to $50 million in mobile ultrasound products of Israel’s Pulsenmore (see here previously). GE will also distribute Pulsenmore’s home pregnancy monitors. Pulsenmore is now developing monitors for chronic heart failure, end-stage renal disease and more.